Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

Enterprise Investors (EI) Fund IX will invest up to €20.4 million in 18GYM, one of Romania's leading fitness chains, acquiring a minority stake.
The Romanian government has adopted an emergency ordinance for administrative reform that officially recognises what specialists have long signalled: public administration is oversized, fragmented and financially unsustainable, according to an opinion by PwC Romania experts Dinu Bumbăcea and Cristian Cortez.
The Romanian government has approved a critical emergency ordinance to maintain capped natural gas prices for household consumers
The European Commission (EC) has approved a €150 million Romanian scheme to support electricity storage, contributing to the transition towards a net-zero economy.
Romania's economy grew 0.7% in real terms in 2025 compared to 2024, though GDP fell 1.9% in Q4 compared to the previous quarter, according to provisional data published by the National Institute of Statistics (INS).